EPR investigation of the active site of recombinant human 5-lipoxygenase:: Inhibition by selenide

被引:27
|
作者
Hammarberg, T [1 ]
Kuprin, S [1 ]
Rådmark, O [1 ]
Holmgren, A [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden
关键词
D O I
10.1021/bi001595d
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoxygenases are a group of non-heme iron dioxygenases which catalyze the formation of lipid hydroperoxides from unsaturated fatty acids. 5-Lipoxygenase (5LO) is of particular interest for formation of leukotrienes and lipoxins, implicated in inflammatory processes. In this study, electron paramagnetic resonance (EPR) spectroscopy was used to investigate the active site iron of purified recombinant human 5-lipoxygenase (5LO), and to explore the action of selenide on 5LO. After oxidation by lipid hydroperoxides, 5LO exhibited axial EPR spectra typified by a signal at g = 6.2. However, removal of the lipid hydroperoxides, their metabolites, and the solvent ethanol from the samples resulted in a shift to more rhombic EPR spectra (g = 5.17 and g = 9.0). Thus, many features of 5LO and soybean lipoxygenase-l EPR spectra were similar, indicating similar flexible iron ligand arrangements in these lipoxygenases. Selenide (1.5 muM) showed a strong inhibitory effect on the enzyme activity of 5LO. In EPR, selenide abolished the signal at g = 6.2, typical for enzymatically active 5LO. Lipid hydroperoxide added to selenide-treated 5LO could not reinstate the signal at g = 6.2, indicating an irreversible change of the coordination of the active site iron.
引用
收藏
页码:6371 / 6378
页数:8
相关论文
共 50 条
  • [41] SELECTIVE 5-LIPOXYGENASE INHIBITION IN ULCERATIVE-COLITIS
    LAURSEN, LS
    NAESDAL, J
    BUKHAVE, K
    LAURITSEN, K
    RASKMADSEN, J
    LANCET, 1990, 335 (8691): : 683 - 685
  • [42] INHIBITION OF ALVEOLAR MACROPHAGE 5-LIPOXYGENASE METABOLISM BY AURANOFIN
    PETERSGOLDEN, M
    SHELLY, C
    BIOCHEMICAL PHARMACOLOGY, 1989, 38 (10) : 1589 - 1595
  • [43] In vitro inhibition of 5-lipoxygenase by natural quinone compounds
    Landa, P.
    Kutil, Z.
    Malik, J.
    Kokoska, L.
    Widowitz, U.
    Marsik, P.
    Bauer, R.
    Vanek, T.
    PLANTA MEDICA, 2011, 77 (12) : 1425 - 1425
  • [44] INHIBITION OF ARACHIDONATE 5-LIPOXYGENASE BY PHENOLIC-COMPOUNDS
    IWAKAMI, S
    SHIBUYA, M
    TSENG, CF
    HANAOKA, F
    SANKAWA, U
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1986, 34 (09) : 3960 - 3963
  • [45] THE PREFERENTIAL INHIBITION OF 5-LIPOXYGENASE PRODUCT FORMATION BY BENOXAPROFEN
    HARVEY, J
    PARISH, H
    HO, PPK
    BOOT, JR
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (01) : 44 - 45
  • [46] ANTHRALIN DERIVATIVES - INHIBITION OF 5-LIPOXYGENASE - ANTIPSORIATIC EFFICACY
    TANZER, H
    BRAUN, C
    SEIDEL, M
    WIEGREBE, W
    ARCHIV DER PHARMAZIE, 1991, 324 (11) : 841 - 846
  • [47] SPECIFIC-INHIBITION AND OXIDATIVE REGULATION OF 5-LIPOXYGENASE
    EGAN, RW
    TISCHLER, AN
    BAPTISTA, EM
    HAM, EA
    SODERMAN, DD
    GALE, PH
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1983, 11 : 151 - 157
  • [48] INHIBITION OF MAMMALIAN 5-LIPOXYGENASE BY 2-BENZYLAMINOPHENOLS
    BUCKLE, DR
    BUMSTEAD, J
    CLARKE, GD
    FOSTER, KA
    PARR, H
    TAYLOR, JF
    THODY, VE
    WEBSTER, RAB
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1988, 33 (01): : 29 - 33
  • [49] Expression of 5-lipoxygenase in human colorectal cancer
    Soumaoro, Labile Togba
    Iida, Satoru
    Uetake, Hiroyuki
    Ishiguro, Megumi
    Takagi, Yoko
    Higuchi, Tetsuro
    Yasuno, Masamichi
    Enomoto, Masayuki
    Sugihara, Kenichi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (39) : 6355 - 6360
  • [50] INTERFACIAL KINETIC REACTION OF HUMAN 5-LIPOXYGENASE
    NOGUCHI, M
    MIYANO, M
    KUHARA, S
    MATSUMOTO, T
    NOMA, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 222 (02): : 285 - 292